This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays
Well Characterized Biologics & Biological Assays is now part of BioProcess International
September 23-26, 2024Hynes Convention Center in Boston, USA
Book Now
Menu
Book Now

Christina Tsai, PhD
Senior Scientist, Lead of Cell Line Development at IGM Biosciences
Speaker

Profile

Christina Tsai is a senior scientist in the Cell Line Development Group in IGM Biosciences. Her work in IGM is focused on CHO cell line development and particularly in the proteomic and genomic identification of cell lines for the production of intact IgM molecules. She has 10+ years of experience in process development in various kinds of cell lines, including CHO, HEK, Pichia, etc. Prior to IGM, she works on cell line development and IgG molecule characterization in Hengenix Biotech and Samsung Biologics. In addition, she founded a microbiome company, EpiBiome, which was acquired by Locus Biosciences.

Agenda Sessions

  • Cell Line Characterization for Cell Line Selection Using Next Generation Sequencing

    , 2:30pm
    View Session

At this event

Prev
Next
Kenn Turner
President and CEO
Massachusetts Life Sciences Center

See Christina at Well Characterized Biologics & Biological Assays

Book Now